FDA's Document Dump: Guidance Release Skyrocketed In Advance Of Trump
Executive Summary
Uncertainty about US FDA's direction under the new president may have spurred staff to ensure views on several issues released before administration changed.
You may also be interested in...
Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’
Incoming president will not hold over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.
FDA Cracks Open Door For More Manufacturer Communications
Two draft guidance documents would allow a broader range of communications with payers and others about information not included on device labeling, or concerning products without FDA approval.
Industry Communications With Payors: US FDA Okays Info On Investigational Drugs
Draft guidance provides clarity on what health care economic information firms can provide to payors, formulary committees and similar entities.